What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review
- 4 April 2013
- journal article
- review article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 73 (5), 861-870
- https://doi.org/10.1136/annrheumdis-2012-203130
Abstract
Objective Initiation of DMARD-therapy in the ‘window of opportunity’ is thought to result in a more effective modification of the processes underlying rheumatoid arthritis (RA). We questioned whether this effect is true or hyped and performed a systematic literature review. Methods Medical literature databases up to June 2012 were systematically reviewed for cohort studies and randomised controlled trials reporting outcome data of early RA in relation with symptom duration at treatment initiation. The quality of these studies was assessed by two independent reviewers using a criteria scoring system of 15 items. Studies were dichotomised with the median score (79%) as cut-off. Best-evidence synthesis was applied to determine the level of evidence per outcome category. A meta-analysis was performed on the studies reporting on achieving DMARD-free sustained remission (the reverse of disease persistency). Results Out of 836 screened articles, 18 fulfilled the selection criteria and were not duplicates. Ten were scored as high quality. Remission (various definitions) and radiographic progression were frequently studied outcomes. There was strong evidence for an association between symptom duration and radiographic progression. A meta-analysis on datasets evaluating DMARD-free sustained remission showed that symptom duration was independently associated with such remission; HR 0.989 (95% CI 0.983 to 0.995) per week increase in symptom duration. A moderate level of evidence was observed for other remission outcomes. Conclusions Even when heterogeneity of patients is taken into account, prolonged symptom duration is associated with radiographic progression and a lower chance on DMARD-free sustained remission. These data may support the presence of a ‘window of opportunity’.Keywords
This publication has 35 references indexed in Scilit:
- Risk Factors for Progression in Hand Osteoarthritis: A Systematic ReviewArthritis Care & Research, 2012
- Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trialsAnnals Of The Rheumatic Diseases, 2012
- Relationship between insulin-like growth factor-1 and radiographic disease in patients with primary osteoarthritis: a systematic reviewOsteoarthritis and Cartilage, 2012
- Sustained drug-free remission in rheumatoid arthritis after DAS-driven or non-DAS-driven therapy: a comparison of two cohort studiesRheumatology, 2012
- Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic?Rheumatology, 2010
- The Michael Mason prize: early rheumatoid arthritis--the window narrowsRheumatology, 2009
- Prevalence of and predictive factors for sustained disease‐modifying antirheumatic drug–free remission in rheumatoid arthritis: Results from two large early arthritis cohortsArthritis & Rheumatism, 2009
- Long‐term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta‐analysisArthritis Care & Research, 2006
- Understanding the window of opportunity concept in early rheumatoid arthritisArthritis & Rheumatism, 2003
- Updated Method Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review GroupSpine, 2003